Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5272566
Max Phase: Preclinical
Molecular Formula: C18H25N3O5S
Molecular Weight: 395.48
Associated Items:
ID: ALA5272566
Max Phase: Preclinical
Molecular Formula: C18H25N3O5S
Molecular Weight: 395.48
Associated Items:
Canonical SMILES: O=C(O)CNC(=O)c1ccc(S(=O)(=O)N2CCC(N3CCCC3)CC2)cc1
Standard InChI: InChI=1S/C18H25N3O5S/c22-17(23)13-19-18(24)14-3-5-16(6-4-14)27(25,26)21-11-7-15(8-12-21)20-9-1-2-10-20/h3-6,15H,1-2,7-13H2,(H,19,24)(H,22,23)
Standard InChI Key: AZZQPUMBONHQSV-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 395.48 | Molecular Weight (Monoisotopic): 395.1515 | AlogP: 0.75 | #Rotatable Bonds: 6 |
Polar Surface Area: 107.02 | Molecular Species: ZWITTERION | HBA: 5 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 2.28 | CX Basic pKa: 8.81 | CX LogP: -2.72 | CX LogD: -2.73 |
Aromatic Rings: 1 | Heavy Atoms: 27 | QED Weighted: 0.74 | Np Likeness Score: -1.46 |
1. Mann MK, Zepeda-Velázquez CA, González-Álvarez H, Dong A, Kiyota T, Aman AM, Loppnau P, Li Y, Wilson B, Arrowsmith CH, Al-Awar R, Harding RJ, Schapira M.. (2021) Structure-Activity Relationship of USP5 Inhibitors., 64 (20.0): [PMID:34648286] [10.1021/acs.jmedchem.1c00889] |
Source(1):